USPTO serial 79026040
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic reagents for medical laboratory use, namely reagents for use in the in vitro diagnosis of urogenital mycoplasms in microbiology | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 23, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Dec 23, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 6, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 6, 2015 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 6, 2015 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 17, 2014 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 17, 2014 | C71T | CANCELLED SECTION 71 | — |
| Sep 19, 2008 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 6, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 6, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 29, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 12, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 5, 2007 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 27, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 13, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 24, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 24, 2007 | ALIE | ASSIGNED TO LIE | — |
| Dec 21, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 20, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2006 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 10, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 26, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 26, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 26, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 25, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 25, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Aug 24, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |